Sudarshan Pharma Industries Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹220.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 31.49 per cent from ₹168.01 crore. This corresponds to a year-on-year *(YoY) growth of 36.72 per cent.
Operating Profit
Operating Profit stands at ₹20.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 85.83 per cent from ₹10.87 crore. This corresponds to a year-on-year *(YoY) growth of 41.46 per cent.
PBDT
PBDT stands at ₹16.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 174.96 per cent from ₹6.11 crore. This corresponds to a year-on-year *(YoY) growth of 56.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹15.71 crore, reflecting a quarter-on-quarter *(QoQ) increase of 202.12 per cent from ₹5.20 crore. This corresponds to a year-on-year *(YoY) growth of 58.85 per cent.
Net Profit
Net Profit stands at ₹11.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 174.70 per cent from ₹4.15 crore. This represents a 53.85 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Sudarshan Pharma Industries Ltd Earnings
- YOY
- QOQ
Sudarshan Pharma Industries Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Sudarshan Pharma Industries Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Sudarshan Pharma Industries Ltd Financial Reports
Sudarshan Pharma Industries Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sudarshan Pharma | -1.80% | -0.27% | 0.07% | 16.90% | 24.72% | -1.73% |
| Sunshield Chem. | -5.44% | -6.27% | 0.97% | 6.67% | -21.32% | 18.34% |
| DMCC Speciality | -2.33% | -2.44% | 9.17% | 31.62% | 13.66% | 24.28% |
| Sadhana Nitro | -2.00% | -7.55% | 6.99% | 47.59% | 32.43% | -58.40% |
| Anlon Healthcare | -2.34% | -5.37% | -7.72% | 10.21% | -15.69% | 45.91% |
| Amal | -1.65% | -4.95% | -15.07% | 1.52% | -18.67% | 5.00% |
| Bhageria Indust. | -2.31% | -4.72% | -2.83% | -2.89% | -20.11% | -18.78% |
Company Info
Company Information
CMD & Director. : Hemal V Mehta
ED / Joint MD / CFO / Promoter : Sachin V Mehta
Independent Non Exe. Director : Umesh Luthra
Independent Non Exe. Director : JAYA ANKUR SINGHANIA
Independent Non Exe. Director : Rushabh Prashant Patil
Non-Exec & Non-Independent Dir : ANIL BALKRISHNA GHOGARE
Company Sec. & Compli. Officer : NIRAV KISHOR KUMAR SHAH